Guangji Pharmaceutical (stock code: 000952.SZ) has issued a profit warning, expecting a net loss attributable to the parent company of 67-83.5 million yuan in the first half of the year.

Smart Financial News APP, Guangji Pharmaceutical (000952.SZ) disclosed its 2025 interim performance forecast. The company is expected to suffer a net loss attributable to shareholders of the listed company of 67-83.5 million yuan for the first half of the year; a net loss of 70-86.5 million yuan after deducting non-recurring gains and losses.